| |
| |
|
| Insider
Information: |
Flint Jonathan A |
| Relationship: |
|
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
10,611,627 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$18,378,381 |
|
|
| Total
Shares |
10,611,627 |
|
|
| Total
Value |
$18,378,381 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
DNIB Upwind Inc |
BIND |
10% Owner |
2013-09-25 |
0 |
2013-09-25 |
2,018,253 |
Premium* |
|
|
Trevena Inc |
TRVN |
10% Owner |
2014-08-13 |
0 |
2014-08-14 |
36,369 |
Premium* |
|
|
X4 Pharmaceuticals Inc |
XFOR |
10% Owner |
2017-11-20 |
0 |
2017-11-20 |
18,031 |
Premium* |
|
|
Lyra Therapeutics, Inc. |
LYRA |
10% Owner |
2020-05-05 |
0 |
2020-05-05 |
7,274 |
Premium* |
|
|
Adagio Therapeutics, Inc. |
ADGI |
|
|
0 |
2022-03-28 |
8,531,700 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADGI |
Adagio Therapeutics, Inc. |
|
– – – |
2022-03-28 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
8,531,700 |
|
% |
|
| LYRA |
Lyra Therapeutics, Inc. |
10% Owner |
– – • |
2020-05-05 |
4 |
B |
$16.00 |
$1,000,000 |
I/I |
62,500 |
7,274 |
1.5 |
- |
|
| LYRA |
Lyra Therapeutics, Inc. |
10% Owner |
– – • |
2020-05-05 |
4 |
S |
$16.00 |
$154,784 |
I/I |
(9,674) |
6,861 |
0 |
- |
|
| LYRA |
Lyra Therapeutics, Inc. |
10% Owner |
– – • |
2020-05-05 |
4 |
OE |
$8.63 |
$154,753 |
I/I |
17,932 |
6,925 |
0 |
- |
|
| LYRA |
Lyra Therapeutics, Inc. |
10% Owner |
– – • |
2020-05-05 |
4 |
A |
$0.00 |
$0 |
I/I |
1,030,094 |
6,807 |
0 |
- |
|
| XFOR |
X4 Pharmaceuticals Inc |
10% Owner |
– – • |
2017-11-20 |
4 |
B |
$10.00 |
$5,000,000 |
I/I |
500,000 |
18,031 |
1.5 |
- |
|
| XFOR |
X4 Pharmaceuticals Inc |
10% Owner |
– – • |
2017-11-20 |
4 |
A |
$0.00 |
$0 |
I/I |
1,368,957 |
13,206 |
0 |
- |
|
| TRVN |
Trevena Inc |
10% Owner |
– – • |
2014-08-14 |
4 |
S |
$6.04 |
$221,680 |
I/I |
(36,702) |
36,369 |
0 |
- |
|
| TRVN |
Trevena Inc |
10% Owner |
– – • |
2014-08-13 |
4 |
S |
$6.12 |
$34,884 |
I/I |
(5,700) |
36,723 |
0 |
- |
|
| BIND |
DNIB Upwind Inc |
10% Owner |
– – • |
2013-09-25 |
4 |
B |
$15.00 |
$390,000 |
I/I |
26,000 |
2,018,253 |
1.5 |
- |
|
| BIND |
DNIB Upwind Inc |
10% Owner |
– – • |
2013-09-25 |
4 |
A |
$0.00 |
$0 |
I/I |
1,992,253 |
1,992,253 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
